Latest Research Collaboration News

Mount Ridley Mines has entered a Material Transfer Agreement with Lawrence Livermore National Laboratory to explore rare earth element processing, marking a strategic move in critical minerals downstream development.

Neometals’ Finnish subsidiary Novana Oy has been awarded a €48.7 million conditional grant from Business Finland to advance its €400 million Vanadium Recovery Project in Pori, aiming to produce up to 60% of Europe’s vanadium demand with a low-carbon footprint.

Archer Materials has partnered with CSIRO to develop cutting-edge quantum machine learning models aimed at revolutionizing fraud detection in financial transactions.

Battery Age Minerals has successfully raised A$5.5 million to accelerate drilling and exploration across three continents, targeting strategic metals vital for future technologies.

Bio-Gene Technology Limited reports significant progress in Q1 FY26, unveiling new product opportunities and positive efficacy data, alongside securing US Department of Defense grants.

White Energy Company Limited has kicked off core drilling at its Specimen Hill Project in Queensland while continuing extensive geochemical exploration at its Tindal Project in the Northern Territory. Meanwhile, its innovative Binderless Coal Briquetting technology is progressing through commercial trials in South Africa.

Noxopharm Limited reports growing interest in its Sofra technology with new research collaborations and a safe, well-tolerated HERACLES trial of SOF-SKN. The company also secures funding extensions to support ongoing development.

Metallium Ltd has marked a pivotal quarter with a U.S. Department of Defense contract award, strategic partnerships, and progress on its Texas Flash Joule Heating plant, positioning itself as a key player in the U.S. critical metals recovery sector.

Proteomics International has expanded its partnership with the University of Melbourne and Royal Women’s Hospital to further validate and develop its PromarkerEndo blood test, aiming to revolutionize endometriosis diagnosis.

INOVIQ Limited has obtained exclusive worldwide rights to novel ovarian cancer biomarker IP from UniQuest, propelling its EXO-OC™ test closer to commercial launch. The test’s exceptional sensitivity and specificity position it as a potential breakthrough in early cancer detection.

Emyria Limited reports a reduced net loss of $3.14 million for FY2025, driven by strategic expansion in psychedelic-assisted mental health treatments and key partnerships including insurer Medibank. The company advances clinical services while continuing R&D on proprietary medicines.

Starpharma reports a significant 183% jump in FY25 revenue to $4.9 million, alongside a 31% reduction in losses and a solid cash position of $15.4 million. The biotech firm’s progress underscores growing momentum in its dendrimer technology pipeline.